why choose us

First received: May 28, 2023

Clinical Trial: Evaluate the Safety and Preliminary Immunogenicity of a SARS-CoV-2 mRNA Vaccine in Adults

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: SARS-CoV-2

Study Type: INTERVENTIONAL


Official Title: Evaluate the Safety and Preliminary Immunogenicity of a SARS-CoV-2 mRNA Vaccine (RBMRNA) as a Booster Dose in Adults

Brief Summary: This study is to evaluate the safety and preliminary immunogenicity of a SARS-CoV-2 mRNA Vaccine as a booster dose in adults who completed 2 doses of inactivated vaccination.

Read more